CoChat

VLDL Triglyceride Kinetics in Lean, Overweight, and Obese Men and Women

Open access
Mittendorfer, Bettina, Yoshino, Mihoko, Patterson, Bruce W., Klein, Samuel · 2016 · The Journal of Clinical Endocrinology & Metabolism

The DOI matches its Crossref record; 45 of the 45 references it cites were found in a registry or an index.

Abstract

CONTEXT: High-plasma very low-density lipoprotein (VLDL) triglyceride (TG) concentration and alterations in VLDL-TG metabolism are associated with cardiometabolic disease. OBJECTIVE: This study sought to evaluate the interrelationships among factors purported to regulate VLDL-TG metabolism in a large cohort of men and women with a wide range in body adiposity and fat distribution but without diabetes. SUBJECTS AND DESIGN: We assessed body composition and fat distribution, plasma insulin concentration, free fatty acid availability, and basal VLDL-TG and VLDL-apoB-100 (VLDL particle number) kinetics in 233 lean, overweight, and obese men and women. RESULTS: We found that: 1) plasma VLDL-TG concentration is determined primarily by VLDL-TG secretion rate (SR) in men and by VLDL-TG clearance rate in women; 2) there is a dissociation between VLDL-TG and VLDL-apoB-100 SRs, and VLDL-apoB-100 SR only explains ∼30% of the variance in VLDL-TG SR; 3) ∼50% of people with obesity have high plasma VLDL-TG concentration due to both an increased VLDL-TG SR and a decreased rate of VLDL-TG plasma clearance, and they have lower plasma high-density lipoprotein-cholesterol concentration and more intra-abdominal and liver fat than those with normal VLDL-TG concentration; and 4) fat-free mass, liver fat content and the rate of free fatty acid release into plasma are independent predictors (with a sex × race interaction) of VLDL-TG SR. CONCLUSIONS: The regulation of plasma VLDL-TG concentration is complex and influenced by multiple metabolic factors. Many people with obesity have normal plasma VLDL-TG concentrations and kinetics, whereas those with high plasma VLDL-TG concentrations have increased VLDL-TG SR and other markers of cardiometabolic disease risk.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1210/jc.2016-1500

Cites

45 of 45 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 45 references

Cited by

See all 108

Metadata

Authors
Mittendorfer, B., Yoshino, M., Patterson, B. W., & Klein, S.
Affiliations
Washington University in St. Louis (US)
Corresponding author
Mittendorfer, Bettina
Venue
The Journal of Clinical Endocrinology & Metabolism
Published
2016-11
Volume
101
Issue
11
Pages
4151-4160
ISSN
  • 0021-972X (ISSN-L)
  • 1945-7197
OpenAlex
W2514898138
Cited by
108
References
45
Citations by year
2026: 11 · 2025: 15 · 2024: 10 · 2023: 7 · 2022: 10 · 2021: 18 · 2020: 16 · 2019: 9 · 2018: 7 · 2017: 4 · 2016: 1
FWCI
5.76
Type
journal article
Language
en
Open access
Locations
  • The Journal of Clinical Endocrinology & Metabolism (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • National Institutes of Health (5p60dk020579-35, 5t32dk007296-35, UL1TR000448)
  • National Institute of General Medical Sciences (P41GM103422)
  • National Institute of Diabetes and Digestive and Kidney Diseases (T32-DK007296, R01DK037948, R01DK094483, P60-DK-020579, P30DK092950, P30DK056341, P30DK020579, T32DK007120)
  • National Institute of Arthritis and Musculoskeletal and Skin Diseases (R01AR049869)
  • National Center for Advancing Translational Sciences
  • Eunice Kennedy Shriver National Institute of Child Health and Human Development (P50HD057796)
Topics
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipid metabolism and disorders
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Cholesterol and Lipid Metabolism
Keywords
obesity, adiposity, body fat distribution, liver fat, intra-abdominal fat, fat-free mass, sex differences, cardiometabolic risk, HDL cholesterol, insulin
MeSH terms
Adipose Tissue, Adolescent, Adult, Female, Humans, Kinetics, Lipoproteins, VLDL, Male, Middle Aged, Obesity, Triglycerides, Body Mass Index, Overweight, Apolipoprotein B-100, Young Adult

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: VLDL Triglyceride Kinetics in Lean, Overweight, and Obese Men and Women. https://app.cochat.ai/papers/10.1210/jc.2016-1500
The paper
Mittendorfer, B., Yoshino, M., Patterson, B. W., & Klein, S. (2016). VLDL Triglyceride Kinetics in Lean, Overweight, and Obese Men and Women. The Journal of Clinical Endocrinology & Metabolism. https://doi.org/10.1210/jc.2016-1500

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.